Reactions Weekly

, Volume 1673, Issue 1, pp 287–287 | Cite as

Omalizumab

Ocular myasthenic syndrome: case report
Case report
  • 34 Downloads

Reference

  1. Kalteren WS, et al. Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report. British Journal of Clinical Pharmacology 83: 2330-2332, No. 10, Jan 2017. Available from: URL: http://doi.org/10.1111/bcp.13338 -NetherlandsCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations